Marco Breinig

Summary

Affiliation: German Cancer Research Center
Country: Germany

Publications

  1. doi request reprint Heat shock protein 90-sheltered overexpression of insulin-like growth factor 1 receptor contributes to malignancy of thymic epithelial tumors
    Marco Breinig
    Department of General Pathology, University Hospital Heidelberg, Heidelberg, Germany
    Clin Cancer Res 17:2237-49. 2011
  2. doi request reprint Expression pattern and functional relevance of epidermal growth factor receptor and cyclooxygenase-2: novel chemotherapeutic targets in pancreatic endocrine tumors?
    Frank Bergmann
    Institute of Pathology, University of Heidelberg, Heidelberg, Germany
    Am J Gastroenterol 104:171-81. 2009
  3. doi request reprint Targeting heat shock protein 90 with non-quinone inhibitors: a novel chemotherapeutic approach in human hepatocellular carcinoma
    Marco Breinig
    Department of General Pathology, University Hospital Heidelberg, Heidelberg, Germany
    Hepatology 50:102-12. 2009
  4. doi request reprint Her2 overexpression is a rare event in anorectal melanoma
    Burkhard Maria Helmke
    Department of General Pathology, Heidelberg University Hospital, Heidelberg, Germany
    Melanoma Res 20:431-4. 2010
  5. doi request reprint Down-regulation of tumor suppressor A kinase anchor protein 12 in human hepatocarcinogenesis by epigenetic mechanisms
    Benjamin Goeppert
    Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany
    Hepatology 52:2023-33. 2010
  6. doi request reprint Establishment, characterization and drug sensitivity testing in primary cultures of human thymoma and thymic carcinoma
    Volker Ehemann
    Institute of Pathology, University Hospital, Heidelberg, Germany
    Int J Cancer 122:2719-25. 2008

Detail Information

Publications6

  1. doi request reprint Heat shock protein 90-sheltered overexpression of insulin-like growth factor 1 receptor contributes to malignancy of thymic epithelial tumors
    Marco Breinig
    Department of General Pathology, University Hospital Heidelberg, Heidelberg, Germany
    Clin Cancer Res 17:2237-49. 2011
    ..Consequently, there is a lack of efficacious targeted therapies and patient prognosis remains dismal, particularly for advanced TEMs. We sought to investigate protumorigenic mechanism relevant to this understudied cancer...
  2. doi request reprint Expression pattern and functional relevance of epidermal growth factor receptor and cyclooxygenase-2: novel chemotherapeutic targets in pancreatic endocrine tumors?
    Frank Bergmann
    Institute of Pathology, University of Heidelberg, Heidelberg, Germany
    Am J Gastroenterol 104:171-81. 2009
    ....
  3. doi request reprint Targeting heat shock protein 90 with non-quinone inhibitors: a novel chemotherapeutic approach in human hepatocellular carcinoma
    Marco Breinig
    Department of General Pathology, University Hospital Heidelberg, Heidelberg, Germany
    Hepatology 50:102-12. 2009
    ..PU-H71 showed potent and prolonged in vivo Hsp90 inhibitory activity and reduced tumor growth without causing toxicity...
  4. doi request reprint Her2 overexpression is a rare event in anorectal melanoma
    Burkhard Maria Helmke
    Department of General Pathology, Heidelberg University Hospital, Heidelberg, Germany
    Melanoma Res 20:431-4. 2010
    ..The results presented here show that isolated cases of AM may benefit from an additive Her2-directed therapy, as the overexpression of Her2 was found in one of our AM patients...
  5. doi request reprint Down-regulation of tumor suppressor A kinase anchor protein 12 in human hepatocarcinogenesis by epigenetic mechanisms
    Benjamin Goeppert
    Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany
    Hepatology 52:2023-33. 2010
    ..We found that miR-183 and miR-186 are up-regulated in CL and DN and are able to target AKAP12...
  6. doi request reprint Establishment, characterization and drug sensitivity testing in primary cultures of human thymoma and thymic carcinoma
    Volker Ehemann
    Institute of Pathology, University Hospital, Heidelberg, Germany
    Int J Cancer 122:2719-25. 2008
    ....